A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder

Bipolar Disorders

Volumn 14, Issue 7, 2012, Pages 697-706

  Mcintyre, Roger S ^a,b,c   Soczynska, Joanna K ^b,c   Woldeyohannes, Hanna O ^c   Miranda, Andrew ^c   Vaccarino, Anthony ^d   Macqueen, Glenda ^e   Lewis, Gary F ^a   Kennedy, Sidney H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d Ontario Cancer Biomarker Network   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bipolar disorder; Cognitive impairment; Intranasal insulin

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HORMONE; HYPNOTIC AGENT; INSULIN; MOOD STABILIZER; PLACEBO;

ADJUVANT THERAPY; ADULT; ANXIETY; ARTICLE; BEDTIME DOSAGE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CALIFORNIA VERBAL LEARNING TEST II; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERANCE; DRUG WITHDRAWAL; EPISTAXIS; EVENING DOSAGE; EXECUTIVE FUNCTION; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPOTHESIS; INSULIN HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NOSE IRRITATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCESS DISSOCIATION PROCEDURE; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE;

ADMINISTRATION, INTRANASAL; ADULT; BIPOLAR DISORDER; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84868088277     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12006     Document Type: Article

References (38)

1. McIntyre RS, Konarski JZ. Bipolar disorder: a national health concern. CNS Spectr 2004; 9 (Suppl. 12): 6-15.
2. MacQueen GM, Young LT, Galway TM, Joffe RT. Backward masking task performance in stable, euthymic out-patients with bipolar disorder. Psychol Med 2001; 31: 1269-1277.
3. Yatham LN, Torres IJ, Malhi GS et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord 2010; 12: 351-363.
4. Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32-40.
5. Martinez-Aran A, Vieta E, Colom F et al. Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000; 69: 2-18.
6. Bowie CR, Depp C, McGrath JA et al. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder. Am J Psychiatry 2010; 167: 1116-1124.
7. Lyoo IK, Sung YH, Dager SR et al. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord 2006; 8: 65-74.
8. van der Heide LP, Ramakers GM, Smidt MP. Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 2006; 79: 205-221.
9. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004; 3: 169-178.
10. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007; 4: 147-152.
11. Benedict C, Brooks SJ, Kullberg J et al. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 2012; 35: 488-494.
12. Watson GS, Craft S. Insulin resistance, inflammation, and cognition in Alzheimer's disease: lessons for multiple sclerosis. J Neurol Sci 2006; 245: 21-33.
13. Benedict C, Hallschmid M, Hatke A et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 2004; 29: 1326-1334.
14. Reger MA, Watson GS, Frey WH et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 2006; 27: 451-458.
15. Reger MA, Watson GS, Green PS et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 2008; 13: 323-331.
16. Schiöth HB, Craft S, Brooks SJ, Frey WH 2nd, Benedict C. Brain insulin signaling and Alzheimer's disease: current evidence and future directions. Mol Neurobiol 2011; doi:10.1007/s12035-011-8229-6.
17. Yatham LN, Kennedy SH, O'Donovan C et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005; 7 (Suppl. 3): 5-69.
18. McIntyre RS, Konarski JZ, Mancini DA et al. Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ 2005; 173: 1327-1334.
19. American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders DSM-IV-TR. 4th ed., text revision ed. Washington, DC: American Psychiatric Association, 2000.
20. Jacoby LL. Invariance in automatic influences of memory: toward a user's guide for the process-dissociation procedure. J Exp Psychol Learn Mem Cogn 1998; 24: 3-26.
21. Delis DC, Freeland J, Kramer JH, Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 1988; 56: 123-130.
22. Reitan R. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
23. Wechsler D. Wechsler Adult Intelligence Scale: WAIS-III. Manual. San Antonio: The Psychological Corporation, 1997.
24. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City: University of Iowa, 1976.
25. MacQueen GM, Grof P, Alda M, Marriott M, Young LT, Duffy A. A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord 2004; 6: 374-378.
26. Zachary RA. Shipley Institute of Living Scale: Revised Manual. Los Angeles: Western Psychological Services, 2000.
27. Trahan DE, Larrabee GJ. Continuous Visual Memory Test: Professional Manual. Odessa: Psychological Assessment Resources, 1988.
28. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21: 1-16.
29. Nelson HE, Willison JR. The Revised National Adult Reading Test-Test Manual. Windsor, England: NFER-Nelson, 1991.
30. Millan MJ, Agid Y, Brune M et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 2012; 11: 141-168.
31. Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J Clin Psychiatry 2012; 73: 103-112.
32. Bora E, Yücel M, Pantelis C, Berk M. Meta-analytic review of neurocognition in bipolar II disorder. Acta Psychiatr Scand 2011; 123: 165-174.
33. MacQueen G, Young T. Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disord 2003; 5 (Suppl. 2): 53-61.
34. Benedict C, Hallschmid M, Schmitz K et al. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 2007; 32: 239-243.
35. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5: 514-516.
36. de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 2006; 10: 89-109.
37. Savitz JB, van der Merwe L, Stein DJ, Solms M, Ramesar RS. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma. Bipolar Disord 2008; 10: 479-494.
38. Goswami U, Sharma A, Varma A et al. The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ. Acta Psychiatr Scand 2009; 120: 456-463.